Published on 06/11/2025 12:39 AM
Caplin Point Laboratories reported an 18% year-on-year increase in net profit to ₹154.4 crore for the July–September quarter of 2025 (Q2FY26), compared to ₹130.8 crore a year earlier. Revenue grew 10.6% to ₹534 crore from ₹483 crore, supported by strong performance across key markets. Earnings before interest, taxes, depreciation and amortisation (EBITDA) rose 15% to ₹189.2 crore, up from ₹164.7 crore last year, while operating margins improved to 35.4% from 34.1%.